ArticleACS medicinal chemistry letters2019

Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors.

Curt D Haffner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.